Resultados de la búsqueda 251-260 of 9731 for Dupuytren’s contracture
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
... disease. Autologous means that these cells that coat the plug come from you. You will be in this study for two years. There is potential to continue to ...
The goal of this research is to investigate the hypothesis that this presentation represents a spatially limited form of CNS inflammatory demyelinating disease.
... disease following an attempt to perform definitive treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes ...
InPACT-neoadjuvant patients are stratified by disease burden as ... disease and factors that may determine disease progression and treatment response.
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from ...
A test based on H3K36me3 loss, a newly identified epigenomic fingerprint, may help providers improve diagnosis and treatment of advanced disease across a wide ...
Page 1.
Tomorrow's Cure: Predicting disease risk with polygenic risk scores Jan. 29, 2025, 02:21 p.m. CDT · Mayo Clinic Q and A: How environmental exposures affect ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?